Multidrug Resistant Tuberculosis: Trends and Control.
Loading...
Date
2014-10
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Multidrug resistant tuberculosis (MDR-TB) has been an area of growing concern and is posing a threat to the control of
tuberculosis (TB). The exact magnitude of problem of resistance to anti-tuberculosis drugs worldwide was not known till
the 1994-97 global project on anti-tuberculosis drug resistance surveillance initiated by the World Health Organization
(WHO) and International Union Against Tuberculosis and Lung Diseases (IUATLD). The Global Tuberculosis Report 2014
estimated that an 3.5% of newly diagnosed and 20.5% of previously treated TB cases had MDR-TB. It has been estimated
that 480,000 cases emerged and 210,000 deaths occurred due to MDR-TB globally in 2013. In India, estimates showed that
the prevalence of MDR-TB among new and previously treated patients was 2.2% and 15%, respectively. It is estimated that
99,000 cases of MDR-TB emerge every year of which 62,000 were among notified cases of TB in 2013. The MDR-TB is a
human-made problem and results largely from poorly managed cases of TB. Adequate, timely diagnosis and optimal
treatment of MDR-TB will help curb the epidemic. Efforts must be focused on the effective use of anti-tuberculosis drugs
in every new patient, so as to prevent the emergence of MDR-TB.
Description
Keywords
Tuberculosis, MDR-TB, Trends
Citation
Prasad R, Gupta N, Singh M. Multidrug Resistant Tuberculosis: Trends and Control. The Indian Journal of Chest Diseases and Allied Sciences, 2014 Oct; 56 (4): 237-246.